• Most Popular
  • Most Shared

Invitrogen to buy CellzDirect for $57 mln

Thu Jan 10, 2008 8:15am EST

CHICAGO, Jan 10 (Reuters) - Invitrogen Corp IVGN.O said on Thursday it would buy privately held CellzDirect Inc for $57 million.

Stocks  |  Mergers & Acquisitions  |  Bonds

Invitrogen, a drug discovery company, said the deal will be neutral to its earnings in fiscal 2008 and add to earnings in fiscal 2009.

CellzDirect, based in Research Triangle Park, North Carolina, provides hepatocyte-based cell products and related services used in the testing of new drugs. Primary human hepatocytes are the most accepted model for predicting a compound's effects on enzymatic metabolism in the liver. (Reporting by Debra Sherman; Editing by John Wallace)

Stocks
Mergers & Acquisitions
Bonds


More from Reuters

Photo

Dubai World says to work with creditors in orderly way

DUBAI (Reuters) - Dubai World, which met its creditors on Monday, said it would work with lenders to seek a debt standstill in "an orderly way" and will get government financial support if an agreement is reached.

» More Top News
A woman shops at a Sam's Club store, a division of Wal-Mart Stores, in Bentonville, Arkansas June 4, 2009. REUTERS/Jessica Rinaldi

The food-stamp economy

On the last day of every month, shoppers at Walmart load their carts with food and household items and wait for the midnight hour. Is this the new normal in America?  Full Article 

U.S.
Two men shake hands in a file photo. REUTERS/File

Let's make a deal

The battered M&A sector will make a tepid recovery in the coming year and three hot sectors will lead the way, according to a Thomson Reuters analysis.  Full Article 

Global Deals Review